Arpa G, Fassan M, Guerini C, et al. Claudin-18 expression in small bowel adenocarcinoma: a clinico-pathologic study. Virchows Arch. 2022;481:853–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bouvier AM, Robaszkiewicz M, Jooste V, et al. Trends in incidence of small bowel cancer according to histology: a population-based study. J Gastroenterol. 2020;55:181–8.

Article  CAS  PubMed  Google Scholar 

Aparicio T, Zaanan A, Svrcek M, et al. Small bowel adenocarcinoma: epidemiology, risk factors, diagnosis and treatment. Dig Liver Dis. 2014;46:97–104.

Article  PubMed  Google Scholar 

Vanoli A, Di Sabatino A, Furlan D, et al. Small bowel carcinomas in coeliac or Crohn’s disease: clinico-pathological, molecular, and prognostic features. A study from the Small Bowel Cancer Italian Consortium. J Crohns Colitis. 2017;11:942–53.

Article  PubMed  Google Scholar 

Vanoli A, Di Sabatino A, Martino M, et al. Small bowel carcinomas in celiac or Crohn’s disease: distinctive histophenotypic, molecular and histogenetic patterns. Mod Pathol. 2017;30:1453–66.

Article  CAS  PubMed  Google Scholar 

Neri G, Arpa G, Guerini C, et al. Small bowel adenocarcinomas featuring special AT-rich sequence-binding protein 2 (SATB2) expression and a colorectal cancer-like immunophenotype: a potential diagnostic pitfall. Cancers (Basel). 2020;12:3441.

Article  CAS  PubMed  Google Scholar 

Giuffrida P, Arpa G, Grillo F, et al. PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability. Mod Pathol. 2020;33:1398–409.

Article  CAS  PubMed  Google Scholar 

Giuffrida P, Vanoli A, Arpa G, et al. Small bowel carcinomas associated with immune-mediated intestinal disorders: the current knowledge. Cancers (Basel). 2018;11:31.

Article  PubMed  Google Scholar 

Locher C, Batumona B, Afchain P, et al. Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up. Dig Liver Dis. 2018;50:15–9.

Article  PubMed  Google Scholar 

Benson AB, Venook AP, Al-Hawary MM, et al. Small bowel adenocarcinoma, version 1.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17:1109–33.

Article  PubMed  PubMed Central  Google Scholar 

Schrock AB, Devoe CE, McWilliams R, et al. Genomic profiling of small-bowel adenocarcinoma. JAMA Oncol. 2017;3:1546–53.

Article  PubMed  PubMed Central  Google Scholar 

Tatsuguchi A, Yamada T, Ueda K, et al. Genetic analysis of Japanese patients with small bowel adenocarcinoma using next-generation sequencing. BMC Cancer. 2022;22:723.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lebwohl B, Sanders DS, Green PHR. Coeliac disease. Lancet. 2018;391:70–81.

Article  PubMed  Google Scholar 

Biagi F, Corazza GR. Mortality in celiac disease. Nat Rev Gastroenterol Hepatol. 2010;7:158–62.

Article  PubMed  Google Scholar 

Biagi F, Schiepatti A, Maiorano G, et al. Risk of complications in coeliac patients depends on age at diagnosis and type of clinical presentation. Dig Liver Dis. 2018;50:549–52.

Article  PubMed  Google Scholar 

Biagi F, Marchese A, Ferretti F, et al. A multicentre case control study on complicated coeliac disease: two different patterns of natural history, two different prognoses. BMC Gastroenterol. 2014;14:139.

Article  PubMed  PubMed Central  Google Scholar 

Emilsson L, Semrad C, Lebwohl B, et al. Risk of small bowel adenocarcinoma, adenomas, and carcinoids in a nationwide cohort of individuals with celiac disease. Gastroenterology. 2020;159:1686–94.

Article  PubMed  Google Scholar 

Rizzo F, Vanoli A, Sahnane N, et al. Small-bowel carcinomas associated with celiac disease: transcriptomic profiling shows predominance of microsatellite instability-immune and mesenchymal subtypes. Virchows Arch. 2020;476:711–23.

Article  CAS  PubMed  Google Scholar 

Xu X, Yu T, Wang Z. Discoidin domain receptor 2: a new target in cancer. Oncol Res Treat. 2022;45:205–15.

Article  CAS  PubMed  Google Scholar 

Tu MM, Lee FYF, Jones RT, et al. Targeting DDR2 enhances tumor response to anti-PD-1 immunotherapy. Sci Adv. 2019;5:eaav2437.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lafitte M, Sirvent A, Roche S. Collagen kinase receptors as potential therapeutic targets in metastatic colon cancer. Front Oncol. 2020;10:125.

Article  PubMed  PubMed Central  Google Scholar 

Murray CW, Berdini V, Buck IM, et al. Fragment-based discovery of potent and selective DDR1/2 inhibitors. ACS Med Chem Lett. 2015;6:798–803.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grither WR, Longmore GD. Inhibition of tumor-microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain. Proc Natl Acad Sci U S A. 2018;115:E7786–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang H, Guo M, Wei H, et al. Targeting p53 pathways: mechanisms, structures, and advances in therapy. Sig Transduct Target Ther. 2023;8:92.

Article  CAS  Google Scholar 

Corrao G, Corazza GR, Bagnardi V, et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet. 2001;358:356–61.

Article  CAS  PubMed  Google Scholar 

Elfström P, Granath F, Ye W, et al. Low risk of gastrointestinal cancer among patients with celiac disease, inflammation, or latent celiac disease. Clin Gastroenterol Hepatol. 2012;10:30–6.

Article  PubMed  Google Scholar 

Schiepatti A, Maimaris S, Raju SA, et al. Persistent villous atrophy predicts development of complications and mortality in adult patients with coeliac disease: a multicentre longitudinal cohort study and development of a score to identify high-risk patients. Gut. 2023;72:2095–102.

Article  PubMed  Google Scholar 

Howdle PD, Jalal PK, Holmes GK, et al. Primary small-bowel malignancy in the UK and its association with coeliac disease. QJM. 2003;96:345–53.

Article  CAS  PubMed  Google Scholar 

Schiepatti A, Rej A, Maimaris S, et al. Clinical classification and long-term outcomes of seronegative coeliac disease: a 20-year multicentre follow-up study. Aliment Pharmacol Ther. 2021;54:1278–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Di Sabatino A, Biagi F, Gobbi PG, et al. How I treat enteropathy-associated T-cell lymphoma. Blood. 2012;119:2458–68.

Article  PubMed  Google Scholar 

Overman MJ, Hu CY, Kopetz S, et al. A population-based comparison of adenocarcinoma of the large and small intestine: insights into a rare disease. Ann Surg Oncol. 2012;19:1439–45.

Article  PubMed  Google Scholar 

Subbiah V, Kurzrock R. Universal germline and tumor genomic testing needed to win the war against cancer: genomics is the diagnosis. J Clin Oncol. 2023;4:3100–3.

Article  Google Scholar